Study on prevalance of diabetes mellitus in patients with T.B. under dots strategy

Indian Journal of Tuberculosis

Volumn 61, Issue 1, 2014, Pages 65-71

  Chachra, Vaibhav ^a   Arora, Vijay Kumar ^a,b  

^a SANTOSH MEDICAL COLLEGE   (India)

^b JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Diabetes; DOTS; Tuberculosis

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIRECTLY OBSERVED THERAPY; FEMALE; HUMAN; INDIA; MALE; MICROBIOLOGY; MULTICENTER STUDY; PREVALENCE; TUBERCULOSIS;

CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; INDIA; MALE; PREVALENCE; TUBERCULOSIS;

EID: 84899457416     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Amrit Guptan, Ashok shah: Tuberculosis and Diabetes: An appraisal. Indian J Tuberc 2000; 47: 3.
2. King H, Aubert RE, Herman WH: Global burden of Diabetes 1995-2025: Prevalence, Numerical Estimates and projections. Diabetes Care 1998; 21: 1414.
3. World Health Organisation. WHO Report 2008: Global Tuberculosis control, surveillance, planning, financing. WHO/HTM/TB/2008;393:109-112.
4. Boucot KR et al. Tuberculosis among diabetics: the Philadelphia survey. American Review of Tuberculosis 1952; 65(1:2): 1-50.
5. Oscarsson PNS, H. Incidence and coincidence of diabetes mellitus and pulmonary tuberculosis in a Swedish county. Acta Med Scand Suppl 1958; 335: 22-48.
6. Davidovich D, Aiello CR, Hassan IA. Antitubercular preventive examination in diabetics. Sem Med 1963; 122: 781-4.
7. Nanda, C.N., Tripathy, S.N. Journal of Association of Physicians of India 1968; 16: 714.
8. Lahiri, D.C. and Sen, P.K. Indian J Tuberc 1974; 21: 98-9.
9. Bahulkar, H.V., Lokhandwala, V.A. Tuberculosis-the social evil. Indian Med J 1951 Feb; 45(2): 44-5. quoted by Deshmukh, 1975.
10. Ezung T, Devi NT, Singh NT, Singh TB. Pulmonary tuberculosis and diabetes mellitus-a study. Journl of Indian Medical Association 2002; 100: 376-80.
11. Kawamori R. Diabetes and tuberculosis-bad companions. Kekkaku 2004; 79(1): 25-32.
12. B. I. Restrepo, S. P. Fisher-Hoch, J.G. Crespo, et. al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect 2007; 135: 483-91.
13. Mboussa J, Monabeka H, Kombo M, et. al. Course of pulmonary tuberculosis in diabetics. Rev Pneumol Clin 2003; 59: 39-44.
14. Wang CS, Yang CJ, Chen HC, et al. Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis. Epidemiol Infect 2009; 137: 203-10.
15. Hendy M, Stableforth D. The effect of established diabetes mellitus on the presentation of infiltrative pulmonary tuberculosis in the immigrant Asian community of an inner city area of the United Kingdom. Br J Dis Chest 1983; 77: 87-90.
16. Harries AD-Trans R. Links between diabetes mellitus and tuberculosis: should we integrate screening and care? Soc Trop Med Hyg 01-JAN-2009; 103(1): 1-2.
17. Joy Frank, R.N., Jane F. Wallace, Scott Pardo Ph.D., Joan Lee Parkes, Ph.D. Performance of the CONTOUR®TS Blood Glucose Monitoring System. Journal of Diabetes Science and Technology 2011; 5-1: 198-205.
18. Coleman PG, Thomas DW, Zimmet PZ et al. Community Organizations for diabetes Action, New classification and criteria for the diagnosis of diabetes mellitus; Interpretation of Capillary Blood Glucose Values Revision Date: September 2006
19. Ramachandran A, Snehalatha C, Kapur A, et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001; 44(9): 1094-101.
20. Alfredo Pone de leonMD, Ma, De Lourdes Garcia Garcia, Cecila Garcia Sancho. TB and diabetes in Southern Mexico. Diabetes Care 2004; 27: 1584-90.
21. Alisjahbana B, Sahiratmadja E, Nelwan EJ, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis 2007; 45: 428-35.
22. Banu Rekha VV, Balasubramanian R, Swaminathan S, et al. Sputum conversion at the end of intensive phase of category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: an analysis of risk factors. Indian J Med Res 2007; 126: 452-8.
23. Guler M, Unsal E, Dursun B, et. al. Factors influencing sputum smear and culture conversion time among patients with new cases of pulmonary tuberculosis. Int J Clin Pract 2007; 61: 231-5.
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26: 12-4.
25. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007; 3: 228-45.
26. Dye C, Lonnroth K, Jaramillo E, Williams BG, Raviglione M. Trends in tuberculosis incidence and their determinants in 134 countries. Bull World Health Organ 2009; 87: 683-91.
27. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-6.
28. Creswell J, Raviglione M, Ottmani S, Migliori GB, Uplekar M, et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur Respir J 2011 May; 37(5): 1269-82.
29. Anil K, Anthony D, Harries, Knut Lönnroth, IbC Bygbjerg and Pierre Lefebvre. Diabetes and Tuberculosis-Old associates posing a renewed Public Health Challenge. European Endocrinology 2009; 5(1): 10-2.
30. Pablos-Mendez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997; 87: 574-9.
31. Meghan A Baker, Anthony D Harries, Christie Y Jeon, Jessica E Hart, Knut Lönnroth et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine 2011; 9: 81.
32. Perez-Guzman C, et al. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes. American Journal of Respiratory and Critical Care Medicine 2000; 162: 1738-40.
33. Oursler KK, et al. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors. Clinical Infectious Diseases 2002; 34: 752-9.
34. Bashar M, et al. Increased incidence of multidrug resistant tuberculosis in diabetic patients on the Bellevue Chest Service, 1987 to 1997. Chest 2001; 120: 1514-9.
35. Fisher-Hoch SP, Whitney E, Mccormick JB, Crespo JG, SmithB, Perez AP, et al. Type 2 diabetes and multidrug-resistant tuberculosis. Scand J Infect Dis 2008; 40: 888-93.
36. Suarez-García I, Rodríguez-Blanco A, Vidal-Pérez JL, García-Viejo ML, Jaras-Hernandez MJ, López OJ, et al. Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain. Eur J Clin Microbiol Infect Dis 2009; 28: 325-30.
37. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-53.
38. Raviglione M. XDR-TB: entering the post-antibiotic era? Int J Tuberc Lung Dis 2006; 10: 1185-7.
39. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-21.
40. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196 Suppl. 1: S86-107.
41. Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240-6.
42. Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 2007; 7: 234.